CIAM
ALT icon

Caitong International Asset Management’s Altimmune ALT Stock Holding History

Caitong International Asset Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781 Sell
257
-16,960
-99% -$50.7K ﹤0.01% 1603
2026
Q1 		$53K Buy
17,217
+15,293
+795% +$64.9K 0.01% 767
2025
Q4 		$6.95K Buy
+1,924
New +$8.39K ﹤0.01% 1197
2025
Q3 		– Sell
-239,630
Closed -$927K – 1905
2025
Q2 		$927K Buy
239,630
+238,693
+25,474% +$1.29M 0.66% 27
2025
Q1 		$4.68K Sell
937
-23,399
-96% -$148K ﹤0.01% 1039
2024
Q4 		$175K Buy
+24,336
New +$186K 0.17% 108

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's ALT Position: Q2 2026 in Review

Caitong International Asset Management reduced its Altimmune (ALT) stake by 99% in Q2 2026, selling an estimated $50.7K and leaving 257 shares worth $781. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Caitong International Asset Management first reported a position in ALT in Q4 2024 and has held it in 6 quarters since. The position peaked at $927K in Q2 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Caitong International Asset Management held 257 shares of Altimmune worth $781 as of Q2 2026.
  • Caitong International Asset Management sold 16,960 Altimmune shares in Q2 2026, an estimated $50.7K.
  • Altimmune made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1603 holding.
  • Caitong International Asset Management first reported a position in Altimmune in Q4 2024 and has held it in 6 quarters since.
  • Caitong International Asset Management's Altimmune position peaked at $927K in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.